Impact Factor
3.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.29
2,196 total citations
h5-index
63
h5 depth signal
Cited share
49.8%
264 of 530
Total citations
2,196
Citation footprint
Metric signal
3.84
External metric anchor
Self-citation
1.8%
40 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
2,859
United States
729
Australia
309
Canada
236
Netherlands
184
Citing Fields of Research
Allergies
1,308
Respiratory Support
1,012
Lung Cancer
873
Auto-Inflammatory Disorders
473
Cystic Fibrosis
334
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
19,578
Articles tracked across the journal lifetime
Indexed publication set
530
264 cited publications
Last 12 months
316
26.3 publications/month
Open access share
24.4%
77 OA publications in the last year
Leading citing country
United Kingdom
2,859 citing publications
Leading citing field
Allergies
1,308 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v20n6, Nov. 1965-
v1n1, Mar. 1946-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Respiratory Support
Lung Cancer
Auto-Inflammatory Disorders
Cystic Fibrosis
Issuing & Sponsoring Bodies
Contributor
Association for the Study of Diseases of the Chest
Contributor
British Medical Association
Contributor
Thoracic Society
Broad Categories
Pulmonary Medicine
Allergies
Auto-Inflammatory Disorders
Lung Cancer
Respiratory Support
Cystic Fibrosis
Chronobiology
MeSH Descriptors
Thorax
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1136/thorax-2026-225989
Open DOI
Buy one sleep therapy, get one free: potential benefits of better breathing for your bed partner
03
DOI 10.1136/thorax-2026-225412
Open DOI
Can we improve survival in congenital central hypoventilation syndrome?
04
DOI 10.1136/thorax-2026-225654
Open DOI
Prior antibiotic exposure in community-acquired pneumonia: primarily a diagnostic rather than a prognostic signal
05
DOI 10.1136/thorax-2026-225547
Open DOI
‘From exacerbation counts to calibrated risk: lessons from ACCEPT 3.0-UK for COPD prediction models’
06
DOI 10.1136/thorax-2026-225829
Open DOI
Nintedanib: does one size fit all?
07
DOI 10.1136/thorax-2026-225695
Open DOI
Impact of timing of interstitial lung disease in patients with systemic sclerosis
08
09
DOI 10.1136/thorax-2026-225348
Open DOI
Post-tuberculosis lung health in children and adolescents: beyond cure
10
DOI 10.1136/thorax-2026-225077
Open DOI
Lung function trajectories after pulmonary tuberculosis in children and adolescents: a prospective cohort study
Background Pulmonary tuberculosis during childhood and adolescence may disrupt lung development and alter long-term respiratory health. However, longitudinal data describing post-treatment outcomes in this age group remain scarce. We aim...
Bibliographical & Catalog Notes
Ed. for the Association for the Study of Diseases of the Chest, Mar. 1946-Dec. 1947; for the Thoracic Society, Mar. 1948-
Also issued online.
v. 1 (Mar. 1946)-Will not microfilm; 20040413
Vol. 35, no. 4 (1980)19920910 Notice not published Printed on acid-free paper